Search research articles
Contact Us
Filters
Showing results (71-80 of 124) with videos related to
Page
of 13
Sort By:
Blood Advances
|
October 25, 2019
Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia
Paul Milne, Charlotte Wilhelm-Benartzi, Michael R Grunwald, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 1, 2019
Effect of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant Patients
Issam S Hamadeh, Qing Zhang, Nury Steuerwald, et al.
Blood
|
April 25, 2013
Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation
Farhad Ravandi, Mona Lisa Alattar, Michael R Grunwald, et al.
British Journal of Haematology
|
July 13, 2021
Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis
Sameem Abedin, Nahid Rashid, Mark Schroeder, et al.
Leukemia Research
|
June 26, 2022
Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax
Aleksander L Chojecki, Justin Arnall, Danielle Boselli, et al.
Blood Advances
|
February 12, 2021
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors
Michael R Grunwald, Mei-Jie Zhang, Hany Elmariah, et al.
Transplantation and Cellular Therapy
|
January 4, 2025
Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis
Cindy Lynn Hickey, Mei-Jie Zhang, Mariam Allbee-Johnson, et al.
Transplantation and Cellular Therapy
|
November 14, 2021
Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes
Paul V O'Donnell, Claudio G Brunstein, Ephraim J Fuchs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2025
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
Stephanie J Lee, Brent Logan, Mary M Horowitz, et al.
Haematologica
|
July 6, 2023
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration
Tania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 124) with videos related to
Sort By:
Page
of 13
Blood Advances
|
October 25, 2019
Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia
Paul Milne, Charlotte Wilhelm-Benartzi, Michael R Grunwald, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 1, 2019
Effect of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant Patients
Issam S Hamadeh, Qing Zhang, Nury Steuerwald, et al.
Blood
|
April 25, 2013
Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation
Farhad Ravandi, Mona Lisa Alattar, Michael R Grunwald, et al.
British Journal of Haematology
|
July 13, 2021
Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis
Sameem Abedin, Nahid Rashid, Mark Schroeder, et al.
Leukemia Research
|
June 26, 2022
Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax
Aleksander L Chojecki, Justin Arnall, Danielle Boselli, et al.
Blood Advances
|
February 12, 2021
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors
Michael R Grunwald, Mei-Jie Zhang, Hany Elmariah, et al.
Transplantation and Cellular Therapy
|
January 4, 2025
Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis
Cindy Lynn Hickey, Mei-Jie Zhang, Mariam Allbee-Johnson, et al.
Transplantation and Cellular Therapy
|
November 14, 2021
Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes
Paul V O'Donnell, Claudio G Brunstein, Ephraim J Fuchs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2025
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
Stephanie J Lee, Brent Logan, Mary M Horowitz, et al.
Haematologica
|
July 6, 2023
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration
Tania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Page
of 13